Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Download in electronic PDF format for $75
Abstract: A formulation for preparing Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
formulation, candesartan cilexetil, hypertension, high blood pressure, antihypertensive agent, racemic mixture
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 315
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 232
|
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 147
|
Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 234
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Oral Liquid Vehicles, Featured Excipient:
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 65-67
|
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 412
|
Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 139
|
Featured Excipient: Plasticizers
Allen Loyd V Jr
|
Mar/Apr 2003
Pg. 145-148
|
Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
|
Jan/Feb 2003
Pg. 48-50
|
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
|
Nov/Dec 2005
Pg. 456-461
|
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
|
Mar/Apr 2015
Pg. 152-160
|
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A, Cauffield Jacintha
|
Mar/Apr 2005
Pg. 117-119
|
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A, Cauffield Jacintha
|
May/Jun 2005
Pg. 201-205
|
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 43
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 142
|
Return to Top |